Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock · CUSIP: 03828A101
Event date: 2025-12-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Propel Bio Management, LLC
Shares: 6,015,394.00 · Class: 4.2%
- Leen Kawas
Shares: 6,015,394.00 · Class: 4.2%
- Richard Kayne and Suzanne Kayne Living Trust dtd 01/14/1999
Shares: 0.00 · Class: 0.0%
- Richard Kayne
Shares: 6,015,394.00 · Class: 4.2%
- Propel Bio Partners LLC
Shares: 6,015,394.00 · Class: 4.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001969764-25-000005
- Form type
- SCHEDULE 13G/A
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Dec 31, 2025
- Reporting period
- Dec 29, 2025
- Description
- Schedule 13G beneficial ownership